The case against mandatory listing of dietary supplements

A dietary supplement industry already seeing FDA as ineffective at enforcing the wealth of existing regulations now faces potential additional requirements.

August 16, 2021

1 Min Read
Short Legal Briefs E4

The discussions around modernizing the Dietary Supplement Health and Education Act (DSHEA) have included a proposal from FDA about developing a mandatory product listing. The agency has said such a listing could be implemented with minimal burden to industry, while the increased visibility into the market would significantly improve oversight and benefit consumers. If such a mandate is included in a so-called DSHEA 2.0 update, what would it mean for responsible supplement companies already following laws and regulations, as well as “bad actors” already disregarding similar requirements imposed on the supplement industry?

Host Josh Long taps three industry insiders to highlight their criticisms of a mandatory product listing,

  • Mitch Coven, founder and CEO, Vitality Works

  • Aaron Secrist, executive VP of quality, R&D and operations, NOW Health Group

  • Steven Shapiro, of counsel, Rivkin Radler LLP

For all episodes, including the previous episode in which two lawyers expressed their support for a mandatory product listing, visit the Short Legal Briefs show page.

 

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like